EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC 4.0

Genotypic and phenotypic characterisation of RP2 ‐ and RPGR ‐associated X‐linked inherited retinal dystrophy, including female manifestations

Shilpa E Kuruvilla, Eileen Song, Naz Raoof, Katherine van Bysterveldt, Verity F Oliver, Sheng Chiong Hong iD, Rasha Al-Taie, Graham Wilson iD, Andrea L Vincent iD

Clinical & Experimental Ophthalmology · 2023

DOI: 10.1111/ceo.14220 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Clinical & Experimental Ophthalmology, 2023. Verfasst von Shilpa E Kuruvilla und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Faculty of Medical and Health Sciences, New Zealand National Eye Centre, University of Auckland, Auckland, New Zealand. Hauptthemen laut MEDLINE: Eye Proteins, Genetic Diseases, X-Linked, GTP-Binding Proteins, Membrane Proteins. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: PBRF, Faculty of Medical and Health Sciences, University of Auckland, Ombler Trust, Retina New Zealand.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

With the promise of gene replacement therapy, eligible males and females with X‐linked inherited retinal dystrophy (XL‐IRD) should be identified.

Methods

Retrospective observational cohort study to establish the phenotypic and genotypic spectrum of XL‐IRD within New Zealand (NZ). Thirty‐two probands, including 9 females, with molecularly proven XL‐IRD due to RP2 or RPGR mutations, and 72 family members, of which 43 were affected, were identified from the NZ IRD Database. Comprehensive ophthalmic phenotyping, familial cosegregation, genotyping, and bioinformatics were undertaken. Main outcome measures were: RP2 and RPGR pathogenic variant spectrum, phenotype in males and females (symptoms, age of onset, visual acuity, refraction, electrophysiology, autofluorescence, retinal appearance), and genotype–phenotype correlation.

Results

For 32 families, 26 unique pathogenic variants were identified; in RP2 ( n = 6, 21.9% of all families), RPGR exons 1–14 ( n = 10, 43.75%), and RPGR‐ ORF15 ( n = 10, 34.3%). Three RP2 and 8 RPGR exons 1–14 variants are novel, rare, and cosegregate. Thirty‐one percent of carrier females were significantly affected, with 18.5% of families initially classified as autosomal dominant. Of five Polynesian families, 80% had novel disease‐causing variants. One Māori family showed keratoconus segregating with an ORF15 variant.

Conclusions

Significant disease was present in 31% of genetically proven female carriers, often leading to an erroneous presumption of the inheritance pattern. Pathogenic variants in 44% of the families were in exon 1–14 of RPGR , more frequent than usually described, which may inform the gene testing algorithm. Proving cosegregation in families for novel variants and identifying affected females and males translates to optimised clinical care and potential for gene therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eye ProteinsGenetic Diseases, X-LinkedGTP-Binding ProteinsMembrane ProteinsRetinal DystrophiesRetinitis PigmentosaFemaleHumansMaleDNA Mutational AnalysisGenotypeIntracellular Signaling Peptides and ProteinsMutationPedigreePhenotypeRetrospective StudiesNew Zealand

Stichwörter der Autor:innen

RP2RPGRX-linkedgeneticsinherited retinal dystrophymutation

Substanzen

Eye ProteinsGTP-Binding ProteinsIntracellular Signaling Peptides and ProteinsMembrane ProteinsRP2 protein, humanRPGR protein, human

Autor:innen und Institutionen

  • Department of Ophthalmology, Faculty of Medical and Health Sciences, New Zealand National Eye Centre, University of Auckland, Auckland, New Zealand.
  • Eye Department, Greenlane Clinical Centre, Auckland District Health Board, Auckland, New Zealand.
  • Eye Department - Gisborne Hospital, Hauora Tairawhiti, Gisborne, New Zealand.
  • Department of Ophthalmology, Manukau Super Clinic, Counties Manukau District Health Board, Manukau, New Zealand.

ORCID-Profile: Sheng Chiong Hong, Graham Wilson, Andrea L Vincent

Förderung

  • PBRF, Faculty of Medical and Health Sciences, University of Auckland
  • Ombler Trust
  • Retina New Zealand
  • Save Sight Society NZ

Zitieren

APA

Kuruvilla, S. E., Song, E., Raoof, N., van Bysterveldt, K., Oliver, V. F., Hong, S. C., Al-Taie, R., Wilson, G., & Vincent, A. L. (2023). Genotypic and phenotypic characterisation of RP2 ‐ and RPGR ‐associated X‐linked inherited retinal dystrophy, including female manifestations. Clinical & Experimental Ophthalmology. https://doi.org/10.1111/ceo.14220

Vancouver

Kuruvilla SE, Song E, Raoof N, van Bysterveldt K, Oliver VF, Hong SC, et al. Genotypic and phenotypic characterisation of RP2 ‐ and RPGR ‐associated X‐linked inherited retinal dystrophy, including female manifestations. Clinical & Experimental Ophthalmology. 2023. doi:10.1111/ceo.14220

BibTeX
@article{Kuruvilla2023,
  author = {Kuruvilla, Shilpa E and Song, Eileen and Raoof, Naz and van Bysterveldt, Katherine and Oliver, Verity F and Hong, Sheng Chiong and Al-Taie, Rasha and Wilson, Graham and Vincent, Andrea L},
  title = {Genotypic and phenotypic characterisation of RP2 ‐ and RPGR ‐associated X‐linked inherited retinal dystrophy, including female manifestations},
  journal = {Clinical & Experimental Ophthalmology},
  year = {2023},
  doi = {10.1111/ceo.14220}
}
Kostenlos starten →